140
Participants
Start Date
March 5, 2015
Primary Completion Date
March 27, 2018
Study Completion Date
August 24, 2023
DFMO
Subjects will receive twenty-seven (27) cycles of oral DFMO at a dose of 500 to 1000 mg/m2 BID on each day of a 28 day cycle.
The Children's Hospital at Montefiore, The Bronx
Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
Levine Children's Hospital, Charlotte
Medical University of South Carolina, Charleston
Arnold Palmer Hospital for Children, Orlando
All Children's Hospital Johns Hopkins Medicine, St. Petersburg
Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville
Nationwide Children's Hospital, Columbus
Helen DeVos Children's Hospital, Grand Rapids
Children's Hospital and Clinics on Minnesota, Minneapolis
Cardinal Glennon Children's Medical Center, St Louis
Children's Mercy Hospitals and Clinics, Kansas City
Arkansas Children's Hospital, Little Rock
Children's Medical Center, Dallas
Texas Children's Cancer and Hematology Centers, Houston
Dell Children's Blood and Cancer Center, Austin
Primary Children's Hospital, Salt Lake City
Phoenix Children's Hospital, Phoenix
Rady Children's Hospital, San Diego
Kapiolani Medical Center for Women and Children, Honolulu
Connecticut Children's Hospital, Hartford
Tufts Medical Center, Boston
Collaborators (1)
Beat NB Cancer Foundation
OTHER
Because of Ezra
OTHER
K C Pharmaceuticals Inc.
INDUSTRY
Giselle Sholler
OTHER